Diabetes: GE invests in non-invasive continuous glucose monitors | Funding Roundup

December 2, 2011 by MassDevice staff

GE Healthcare invests in non-invasive continuous glucose monitoring with C8 Medisensors' light-spectroscopy device.

GE Healthcare logo

GE Healthcare (NYSE: GE) invested an undisclosed amount into C8 Medisensors, a developer of non-invasive continuous glucose monitors for diabetic patients.

C8 aims to provide glucose monitoring that is "painless, accurate, continuous, noninvasive, and nonintrusive to your life," according to its website.

The San Jose, Calif.-based company's glucose monitors use light spectroscopy to measure blood glucose levels without the need for frequent finger pricks.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.